Sio Gene Therapies Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K12G3 on 11/13/2020   Download
SEC Document
SEC Filing
Effective November 12, 2020, Axovant Gene Therapies Ltd. (“Axovant”) changed its jurisdiction of incorporation from Bermuda to the State of Delaware (the “Domestication”) and changed its legal name to Sio Gene Therapies Inc. (“we,” “us,” “our” or the “Company”) in connection with the Domestication. Axovant discontinued its existence as a Bermuda exempted company as provided under Sections 132G and 132H of The Companies Act 1981 of Bermuda and, pursuant to Section 388 of the General Corporation Law of the State of Delaware continued its existence as a corporation incorporated in the State of Delaware.